Narenraj Arulprakash
Researcher
University of Arkansas for Medical Sciences
faculty
Research Areas
Links
Is this your profile? Verify and claim your profile
Biography and Research Information
OverviewAI-generated summary
Narenraj Arulprakash's research focuses on neurological disorders and their management, particularly in the context of critical care and infectious diseases. His work has investigated the neurological manifestations of COVID-19, including acute encephalopathy and its association with patient outcomes, as well as the underutilization of stroke and neurocritical care during the pandemic. Arulprakash has also explored specific neurological conditions such as Wernicke's encephalopathy, examining its atypical clinical presentations and neuroimaging findings, and Cerebellar restricted diffusion. Additionally, his research extends to the pharmacological effects of medications, such as ticagrelor and clopidogrel, on platelet aggregation and inflammatory burden in patients with chronic kidney disease. He has also published on immune checkpoint inhibitor-induced myasthenia gravis. Arulprakash collaborates with researchers at the University of Arkansas for Medical Sciences and the University of Arkansas at Little Rock.
Metrics
- h-index: 4
- Publications: 12
- Citations: 79
Selected Publications
- Case of Immune Checkpoint Inhibitor Induced Myasthenia Gravis (2024) DOI
- Atypical Clinical Presentations and Neuroimaging Findings of Wernicke Encephalopathy (P4-4.004) (2023) DOI
- Ticagrelor inhibits platelet aggregation and reduces inflammatory burden more than clopidogrel in patients with stages 4 or 5 chronic kidney disease (2023) DOI
- Cerebellar restricted diffusion in Wernicke’s encephalopathy (2022) DOI
- Continued Underutilization of stroke care during the COVID-19 pandemic (2021) DOI
Collaborators
Researchers in the database who share publications
Similar Researchers
Based on overlapping research topics